These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6496281)

  • 1. The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: an electrophysiologic correlation.
    Ezri MD; Huang SK; Denes P
    Am Heart J; 1984 Nov; 108(5):1229-36. PubMed ID: 6496281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of ambulatory electrocardiographic monitoring for predicting recurrence of sustained ventricular tachyarrhythmias in patients receiving amiodarone.
    Sokoloff NM; Spielman SR; Greenspan AM; Rae AP; Brady PM; Kay HR; Horowitz LN
    J Am Coll Cardiol; 1986 Apr; 7(4):938-41. PubMed ID: 3958353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia.
    Kim SG; Felder SD; Figura I; Johnston DR; Waspe LE; Fisher JD
    J Am Coll Cardiol; 1987 Jan; 9(1):169-74. PubMed ID: 3794093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia.
    Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR
    Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of ambulatory monitoring in the prognostic evaluation of patients with sustained ventricular tachycardia treated with amiodarone.
    Veltri EP; Griffith LS; Platia EV; Guarnieri T; Reid PR
    Circulation; 1986 Nov; 74(5):1054-60. PubMed ID: 3769165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of early electrophysiologic studies for ventricular tachycardia recurrence in patients with coronary artery disease treated with amiodarone.
    Manolis AS; Uricchio F; Estes NA
    Am J Cardiol; 1989 May; 63(15):1052-7. PubMed ID: 2705375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of life-threatening ventricular tachycardia with encainide hydrochloride in patients with left ventricular dysfunction. The Encainide-Ventricular Tachycardia Study Group.
    Am J Cardiol; 1988 Sep; 62(9):571-5. PubMed ID: 3137797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
    Veltri EP; Reid PR; Platia EV; Griffith LS
    J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ; Mann DE; Reiffel JE; Hahn E; Hartz V
    Circulation; 1995 Apr; 91(7):1988-95. PubMed ID: 7895357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA
    Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?
    Kim SG; Seiden SW; Felder SD; Waspe LE; Fisher JD
    N Engl J Med; 1986 Aug; 315(6):356-62. PubMed ID: 2426592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Out-of-hospital cardiac arrest in patients with no overt heart disease: electrophysiologic observations and clinical outcome.
    Bhandari AK; Hong R; Au P; McKay CR; Rahimtoola SH
    Can J Cardiol; 1988 Mar; 4(2):80-4. PubMed ID: 3365601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant metoprolol improves efficacy of class I antiarrhythmic drugs in patients with inducible sustained monomorphic ventricular tachycardia.
    Brodsky MA; Chough SP; Allen BJ; Capparelli EV; Orlov MV; Caudillo G
    Am Heart J; 1992 Sep; 124(3):629-35. PubMed ID: 1514490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of Holter monitoring in selecting pharmacologic therapy for patients with sustained monomorphic ventricular tachycardia: studies in patients in whom no effective pharmacologic therapy could be determined by electrophysiologic study.
    Niwano S; Furushima H; Taneda K; Abe A; Ohira K; Aizawa Y
    Jpn Circ J; 1998 May; 62(5):347-52. PubMed ID: 9626902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
    Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
    Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.
    Roberts SA; Viana MA; Nazari J; Bauman JL
    Pacing Clin Electrophysiol; 1994 Oct; 17(10):1590-602. PubMed ID: 7800560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ; Karagounis LA; Mann DE; Reiffel JA; Hahn E; Hartz V
    Am J Cardiol; 1997 Feb; 79(3):315-22. PubMed ID: 9036751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.